METASTATIC ALVEOLAR SOFT PART SARCOMA
Clinical trials for METASTATIC ALVEOLAR SOFT PART SARCOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC ALVEOLAR SOFT PART SARCOMA trials appear
Sign up with your email to follow new studies for METASTATIC ALVEOLAR SOFT PART SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could less be more? new study tests lower cancer drug doses to cut side effects
Disease control Recruiting nowThis study tests whether giving a lower, less frequent dose of the cancer drug atezolizumab can still control tumors while causing fewer side effects. About 30 adults with advanced lung, liver, skin, or sarcoma cancers will receive the drug alone or with other treatments. Researc…
Matched conditions: METASTATIC ALVEOLAR SOFT PART SARCOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 16, 2026 22:46 UTC
-
New drug combo aims to shrink rare sarcomas
Disease control Recruiting nowThis study tests whether combining atezolizumab (an immunotherapy) with selinexor (a drug that blocks a cancer-growth protein) can shrink tumors in people with advanced alveolar soft part sarcoma (ASPS), a rare cancer. About 27 adults whose cancer has spread or cannot be removed …
Matched conditions: METASTATIC ALVEOLAR SOFT PART SARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 16, 2026 22:42 UTC